The European Commission (EC) has granted conditional marketing authorization for Pfizer's Bosulif (bosutinib) anti-cancer drug in the European Union (EU). Bosulif is authorized in Europe for the treatment of adult patients with chronic ...
Tags: Pfizer Bosulif, cancer drug, drug
Abbott has entered into a collaboration agreement with Janssen Biotech and Pharmacyclics to develop a molecular companion diagnostic test for investigational leukemia therapy. Under the agreement, Abbott will leverage its proprietary ...
Tags: leukemia therapy, Abbott, Pharmacyclics
Sequenta has introduced a sequencing-based test for minimal residual disease (MRD) for leukemia and lymphoma. The ClonoSIGHT test utilizes the company's proprietary LymphoSIGHT technology, which works by sequencing DNA signatures that are ...
Tags: Sequenta, sequencing-based test, minimal residual disease
Pfizer's bosutinib has received positive opinion for the conditional marketing authorization from the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP). The bosutinib positive CHMP opinion is concerned with ...
Fluorescence In Situ Hybridisation (FISH) is used in the leukemia diagnostics to determine the specific type of leukemia disease. Samples of blood or bone marrow are used in a short term cell culture to receive cells in the metaphase ...
Tags: FISH, leukemia disease, bone marrow
Amarantus BioScience has purchased all of the intellectual property (IP) assets from Power3 Medical Products. Power3 was in bankruptcy and the company has acquired the IP assets for $40,000 which includes technology related to the ...
Tags: Amarantus BioScience, intellectual property, Power3 Medical Products
In light of the holiday season, two auto repair companies donated refurbished vehicles for families in need. In Redlands, Calif., Caliber Collision made its fourteenth recycled ride donation to the family of an 11-year-old boy with ...
Tags: auto repair, auto industry, recycled ride, car
Malaysian residents opposed to a rare earths processing facility have launched a legal challenged that threatens to delay the project put forward by Australia's Lynas Corp. Reuters reports the court action would force the government to ...
Tags: Lynas Corp, Malaysia, Rare Earth, Metallurgy
Sequenta has obtained clinical laboratory improvement amendments (CLIA) certification for its new clinical test, which is based on the LymphoSIGHT method. The LymphoSIGHT platform, which utilizes a proprietary assay for the amplification ...
Tags: Sequenta, CLIA, certification, clinical test, LymphoSIGHT method
NeoGenomics has introduced NeoTYPE prognostic panel for detection of mutations in splicing factor 3b subunit 1 (SF3B1) gene of chronic lymphocytic leukemia (CLL) in the US. The CLL Profile panel also includes assays for IgVH mutation ...
Tags: NeoGenomics, prognostic panel, CLL Profile panel, FISH tests
US based Ariad Pharmaceuticals has submitted New Drug Application (NDA) for its investigational BCR-ABL inhibitor, ponatinib for the approval of US Food and Drug Administration (FDA). Ponatinib is indicated for patients with resistant or ...
Tags: BCR-ABL inhibitor, CML, Ph+ALL
The US Food and Drug Administration (FDA) has granted accelerated approval to Talon Therapeutics' Marqibo (vinCRIStine sulfate LIPOSOME injection). Marqibo, a sphingomyelin/cholesterol liposome-encapsulated formulation of vincristine ...
The European Commission (EC) has granted orphan drug designation to Sunesis Pharmaceuticals' Vosaroxin drug. Vosaroxin is a first-in-class anti-cancer quinolone derivative, (AQD), used for the treatment of acute myeloid leukemia (AML). ...
Tags: vosaroxin, AQD, AML, anti-cancer quinolone derivative
Jazz Pharmaceuticals has initiated patient dosing in a clinical trial intravenously (IV) administering Erwinaze in acute lymphoblastic leukemia (ALL) patients hypersensitive to asparaginase therapy derived from E. coli. The trial will ...
Tags: pharmeceuticals, clinical, trial intravenously, E.coli
Roche has unveiled GS GType TET2/CBL/KRAS and GS GType RUNX1 primer set for high sensitivity genetic variant detection in leukemia samples. The sequence-based assays utilize the company's 454 GS Junior and GS FLX systems and enable deep ...
Tags: Roche, GS GType TET2/CBL/KRAS, GS GType RUNX1 primer set